{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T19:03:43Z","timestamp":1775847823314,"version":"3.50.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background and objectives<\/jats:title><jats:p>An increasing number of patients with antithrombotic therapies are undergoing endoscopic retrograde cholangiopancreatography (ERCP). Interruption of antithrombotic therapies may be associated with a higher risk of symptomatic thromboembolic (TE) events. We aimed to investigate the risk of symptomatic TE events among patients undergoing ERCP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective cohort study on patients at risk for symptomatic TE events who had undergone ERCP from January 2016 to October 2023 was conducted. A total of 2,482 patients who had undergone ERCP were included in this study. We compared the risk of symptomatic TE events within 30\u202fdays after ERCP between the group treated with antithrombotic agent and the group not treated with antithrombotic agent using multivariate regression analysis adjusted for covariates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 15 patients (0.60%, 15\/2,482) developed symptomatic TE events within 30\u202fdays after ERCP. The symptomatic TE event rate in subjects on any antithrombotic drug was 1.46% with an odds ratio (OR) of 5.267 (<jats:italic>n<\/jats:italic>\u202f=\u202f689, 95% CI 1.79\u201315.46, <jats:italic>p<\/jats:italic>\u202f=\u202f0.002), compared with those not treated with antithrombotic drugs (<jats:italic>n<\/jats:italic>\u202f=\u202f1,793). The symptomatic TE event rate in subjects on temporary interruption of antithrombotic drugs was 1.48% with an OR of 5.36 (<jats:italic>n<\/jats:italic>\u202f=\u202f677, 95% CI 1.83\u201315.74, <jats:italic>p<\/jats:italic>\u202f=\u202f0.002), compared with those not treated with antithrombotic drugs (<jats:italic>n<\/jats:italic>\u202f=\u202f1,793). Multivariate regression analysis indicated that patients with high-risk conditions had a significantly higher risk of post-ERCP symptomatic TE events (adjusted OR 11.73, 95% CI 2.23\u201361.70).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Interruption of antithrombotic drugs is associated with higher post-ERCP symptomatic TE events, particularly in high-risk conditions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1453026","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T07:10:30Z","timestamp":1738825830000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Observation of symptomatic thromboembolic events in endoscopic retrograde cholangiopancreatography patients with interruption of antithrombotic therapies"],"prefix":"10.3389","volume":"12","author":[{"given":"Jinqing","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianglong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gie.2016.06.051","article-title":"Adverse events associated with ERCP","volume":"85","author":"Chandrasekhara","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S2468-1253(19)30337-1","article-title":"US cooperative for outcomes research in endoscopy (USCORE). Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial. Lancet","volume":"5","author":"Fogel","year":"2020","journal-title":"Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"934","DOI":"10.14309\/ajg.0000000000000623","article-title":"Real-world practice patterns in the era of rectal indomethacin for prophylaxis against post-ERCP pancreatitis in a high-risk cohort","volume":"115","author":"Smith","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.gie.2023.01.043","article-title":"Risk of post-sphincterotomy bleeding with antiplatelet and anticoagulant use: a propensity-matched analysis of the U.S. collaborative network","volume":"97","author":"Chandan","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.gie.2020.04.038","article-title":"Antiplatelet and\/or anticoagulant treatment does not increase hemorrhagic adverse events during EUS-guided biliary drainage","volume":"92","author":"Ogura","year":"2020","journal-title":"Gastrointest Endosc"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.gie.2022.12.025","article-title":"Association between perioperative management of antiplatelet agents and risk of post-endoscopic submucosal dissection bleeding in early gastric cancer: analysis of a nationwide multicenter study","volume":"97","author":"Miura","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"JC74","DOI":"10.7326\/J22-0041","article-title":"ACG-CAG provided suggestions for periendoscopic management of anticoagulants and antiplatelets","volume":"175","author":"Lichtenstein","year":"2022","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.gie.2020.02.038","article-title":"Impact of direct-acting oral anticoagulants and warfarin on postendoscopic GI bleeding and thromboembolic events in patients undergoing elective endoscopy","volume":"92","author":"Tien","year":"2020","journal-title":"Gastrointest Endosc"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"542","DOI":"10.14309\/ajg.0000000000001627","article-title":"American College of Gastroenterology-Canadian Association of Gastroenterology clinical practice guideline: management of anticoagulants and antiplatelets during acute gastrointestinal bleeding and the periendoscopic period","volume":"117","author":"Abraham","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.gie.2018.08.028","article-title":"Comparison of the effects of antithrombotic therapy on delayed bleeding after gastric endoscopic resection: a propensity score-matched case-control study","volume":"89","author":"So","year":"2019","journal-title":"Gastrointest Endosc"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.gie.2020.07.030","article-title":"Safety and effectiveness of peroral endoscopic myotomy in patients on antiplatelet or anticoagulant therapy: an international multicenter case-control study","volume":"93","author":"Rodr\u00edguez de Santiago","year":"2021","journal-title":"Gastrointest Endosc"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1016\/j.cgh.2022.09.021","article-title":"Risk of Postcolonoscopy thromboembolic events: a real-world cohort study","volume":"21","author":"Li","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10120-020-01105-0","article-title":"Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study","volume":"24","author":"Tomida","year":"2021","journal-title":"Gastric Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/gutjnl-2017-315131","article-title":"Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines","volume":"67","author":"Chan","year":"2018","journal-title":"Gut"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.gie.2013.08.028","article-title":"Trends in utilization of diagnostic and therapeutic ERCP and cholecystectomy over the past 25 years: a population-based study","volume":"79","author":"Moffatt","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1136\/gutjnl-2021-325184","article-title":"Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update","volume":"70","author":"Veitch","year":"2021","journal-title":"Gut"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.gie.2011.06.015","article-title":"The incidence of deep vein thrombosis in Japanese patients undergoing endoscopic submucosal dissection","volume":"74","author":"Kusunoki","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.gie.2015.09.035","article-title":"The management of antithrombotic agents for patients undergoing GI endoscopy","volume":"83","author":"Acosta","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1055\/s-0034-1392408","article-title":"Bleeding after endoscopic sphincterotomy or papillary balloon dilation among users of antithrombotic agents","volume":"47","author":"Hamada","year":"2015","journal-title":"Endoscopy"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1007\/s00464-022-09138-5","article-title":"Oral anticoagulants but not antiplatelet agents increase the risk of delayed bleeding after endoscopic papillectomy: a large study in a tertiary referral center","volume":"36","author":"Meunier","year":"2022","journal-title":"Surg Endosc"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1111\/j.1572-0241.2008.02216.x","article-title":"American College of Gastroenterology; American Heart Association. ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use","volume":"103","author":"Bhatt","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1007\/s00464-018-6129-9","article-title":"Optimal time of resuming anticoagulant after endoscopic sphincterotomy in patients at risk for thromboembolism: a retrospective cohort study","volume":"32","author":"Paik","year":"2018","journal-title":"Surg Endosc"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12876-021-01980-6","article-title":"Direct oral anticoagulants increase bleeding risk after endoscopic sphincterotomy: a retrospective study","volume":"21","author":"Masuda","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/den.12498","article-title":"Recent clinical management of antithrombotic agents for gastrointestinal endoscopy after revision of guidelines in Japan","volume":"27","author":"Ono","year":"2015","journal-title":"Dig Endosc"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5009\/gnl19133","article-title":"Research Group for Endoscopic Submucosal Dissection in Korean Society of Gastrointestinal Endoscopy. Clinical practice and Guidelines for managing Antithrombotics before and after endoscopy: a National Survey Study. Gut","volume":"14","author":"Jeon","year":"2020","journal-title":"Liver"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.gie.2019.09.033","article-title":"Antiplatelets, anticoagulants, and colonoscopic polypectomy","volume":"91","author":"Abraham","year":"2020","journal-title":"Gastrointest Endosc"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000504597","article-title":"Effects of Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment on postoperative bleeding after endoscopic submucosal dissection for early gastric Cancer: a propensity score-matching analysis","volume":"102","author":"Terasaki","year":"2021","journal-title":"Digestion"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","article-title":"Venous thromboembolism in cancer patients: ESMO clinical practice guideline","volume":"34","author":"Falanga","year":"2023","journal-title":"Ann Oncol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/head.12769","article-title":"The pharmacology of indomethacin","volume":"56","author":"Lucas","year":"2016","journal-title":"Headache"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1453026\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T07:10:32Z","timestamp":1738825832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1453026\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":29,"alternative-id":["10.3389\/fmed.2025.1453026"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1453026","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"article-number":"1453026"}}